291 related articles for article (PubMed ID: 31153708)
1. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
4. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
[TBL] [Abstract][Full Text] [Related]
5. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
6. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
[TBL] [Abstract][Full Text] [Related]
7. Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting.
Fernandez Mosteirin N; Saez Comet L; Salvador Osuna C; Calvo Villas JM; Velilla Marco J
Lupus; 2017 Oct; 26(12):1328-1332. PubMed ID: 28387637
[TBL] [Abstract][Full Text] [Related]
8. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients.
Chanloung W; Kasitanon N; Wichainun R; Louthrenoo W
Int J Rheum Dis; 2021 Dec; 24(12):1510-1519. PubMed ID: 34716670
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.
Sciascia S; Radin M; Sanna G; Cecchi I; Roccatello D; Bertolaccini ML
Rheumatology (Oxford); 2018 Apr; 57(4):661-665. PubMed ID: 29342292
[TBL] [Abstract][Full Text] [Related]
11. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.
Del Barrio-Longarela S; Martínez-Taboada VM; Blanco-Olavarri P; Merino A; Riancho-Zarrabeitia L; Comins-Boo A; López-Hoyos M; Hernández JL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):297-310. PubMed ID: 34910282
[TBL] [Abstract][Full Text] [Related]
12. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D;
Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275
[TBL] [Abstract][Full Text] [Related]
14. The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.
Radin M; Schreiber K; Cecchi I; Roccatello D; Cuadrado MJ; Sciascia S
Eur J Neurol; 2018 Feb; 25(2):320-325. PubMed ID: 29082583
[TBL] [Abstract][Full Text] [Related]
15. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
16. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort.
Zhao Y; Huang C; Qi W; Zhou Y; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507205
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
18. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
20. The global anti-phospholipid syndrome score in primary APS.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Rheumatology (Oxford); 2015 Jan; 54(1):134-8. PubMed ID: 25122726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
